Philips Respironics is recalling 100,126 Trilogy Evo and Trilogy Evo O2 ventilators because the safety labeling failed to include critical instructions regarding patient weight and use. Specifically, the AVAPS-AE therapy mode must not be used on patients weighing less than 22 pounds (10 kg) or for invasive treatments, and the standard AVAPS feature is also unsafe for patients under 22 pounds. Approximately 54,691 of these affected units were distributed across the United States and Puerto Rico.
If these ventilators are used on patients weighing less than 10 kg, it can cause severe lung injury from excessive pressure, insufficient breathing (hypoventilation), or the dangerous buildup and rebreathing of carbon dioxide.
Label correction for safety contraindications.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.